Clinical Trials Directory

Trials / Completed

CompletedNCT02906254

Early Antibiotic Discontinuation in FUO

Early Discontinuation of Empirical Antibacterial Therapy in Febrile Neutropenia: Prospective Observational Study (ANTIBIOSTOP)

Status
Completed
Phase
Study type
Observational
Enrollment
123 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Febrile neutropenia requires prompt initiation of broad-spectrum antibiotics, which can be responsible for side-effects and selection of resistance. This study demonstrates the safety of an early discontinuation of empirical treatments, in carefully selected patients presenting with fever of unknown origin.

Detailed description

Infections are responsible for significant morbidity and mortality in haematological patients, in particular during chemotherapy-induced neutropenia. Guidelines recommend immediate initiation of antibiotic therapy, whose optimal duration is unclear. The primary objective of this study is to evaluate early discontinuation of antibiotic treatment for Fever of Unknown Origin (FUO) in afebrile or febrile neutropenic patients. The secondary objective is to describe the epidemiology of febrile neutropenia (FN) in investigator centre. Every episode of FN was prospectively identified. In the first phase of the study, empirical antibiotic therapy of FUO patients was stopped after 48 hours of apyrexia, in accordance with ECIL-4 (European Conference on Infections in Leukaemia) recommendations. In the second phase of the study, antibiotics were stopped on day 5 for all FUO patients, regardless of their temperature or their leukocyte count.

Conditions

Interventions

TypeNameDescription
OTHERECIL-4 guidelines groupAntibiotics were stopped when patients had been afebrile for more than 48 hours
OTHERShort-course antibiotic therapyAntibiotics were stopped on day 5 in febrile or afebrile patients

Timeline

Start date
2014-02-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2016-09-20
Last updated
2016-09-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02906254. Inclusion in this directory is not an endorsement.